Why Oscar Health (NYSE:OSCR) Stock is Surging: ACA Growth and Strong Financials

• Oscar Health (NYSE:OSCR) has demonstrated exceptional stock performance, with shares up 126% this year, driven by its strong position in the ACA marketplace.
• The company is aggressively expanding its market share, achieving a 47% surge in enrollment year-over-year, showcasing robust demand for its health plans despite overall market declines.
• Positive investment outlook is supported by raised analyst price targets and improved financial guidance, including a better medical loss ratio, leading to a "Strong Buy" rating.

Oscar Health (NYSE:OSCR) is an insurance company that focuses on selling health plans through the Affordable Care Act (ACA) marketplace. The company's stock has performed very well, with shares already up 126% this year. Oscar Health is the second-largest insurer on the ACA exchange by membership, placing it behind its competitor Centene (NYSE:CNC).

The company follows an aggressive strategy to increase its market share. This approach appears successful, as its enrollment has surged by 47% compared to a year ago. This growth comes even as overall enrollment in the market has seen a general decline, showing strong demand for Oscar Health's offerings.

Reflecting this positive momentum, Barclays analyst Andrew Mok has raised the price target for Oscar Health to $49.00 from a previous target of $39.00. Based on the stock's price of $32.34 at the time of the rating, this new target suggests a potential increase of over 51% for investors.

This optimism is supported by the company's own financial updates. Oscar Health recently raised its earnings outlook for the full year and lowered its expected medical costs. This positive sentiment is also shared by others, as Oscar Health was added to the Zacks Rank #1 (Strong Buy) list, as highlighted by Zacks Investment Research.

A key metric showing this improvement is the medical loss ratio, which compares the cost of medical care to the premiums collected. Oscar Health now projects this ratio to be in the 81% to 82% range, an improvement from its prior outlook. A lower ratio is better as it means the company retains more profit.